Chiral Acetals as Stereoinductors: Diastereoface Selective Alkylation of Dihydrobenzoxazine-Derived Amide Enolates
摘要:
Novel dihydrobenzoxazine-derived acetals of type 3 have been developed for asymmetric C-alkylations of propionyl amide enolates. High stereoselectivities are obtained for amides 15 and 22 which are rationalized in terms of intramolecular metal chelate formation.
Chiral Acetals as Stereoinductors: Diastereoface Selective Alkylation of Dihydrobenzoxazine-Derived Amide Enolates
摘要:
Novel dihydrobenzoxazine-derived acetals of type 3 have been developed for asymmetric C-alkylations of propionyl amide enolates. High stereoselectivities are obtained for amides 15 and 22 which are rationalized in terms of intramolecular metal chelate formation.
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
申请人:De Matos N. Marta
公开号:US20070219120A1
公开(公告)日:2007-09-20
A method is disclosed for treating inflammatory disease in an animal in need thereof by administering to the animal a pharmaceutical composition containing an anti-inflammatory effective amount of an organic aldehyde compound or a derivative thereof in a pharmaceutically acceptable vehicle.
US7968605B2
申请人:——
公开号:US7968605B2
公开(公告)日:2011-06-28
[EN] METHODS FOR TREATING INFLAMMATORY DISEASE BY ADMINISTERING ALDEHYDES AND DERIVATIVES THEREOF<br/>[FR] PROCÉDÉS DE TRAITEMENT D'UNE MALADIE INFLAMMATOIRE PAR ADMINISTRATION D'ALDÉHYDES ET DE DÉRIVÉS DE CEUX-CI
申请人:ALFAMA INVESTIGACAO E DESENVOL
公开号:WO2008069688A2
公开(公告)日:2008-06-12
[EN] A method is disclosed for treating inflammatory disease in an animal in need thereof by administering to the animal a pharmaceutical composition containing an anti-inflammatory effective amount of an organic aldehyde compound or a derivative thereof in a pharmaceutically acceptable vehicle. [FR] L'invention concerne un procédé de traitement d'une maladie inflammatoire chez un animal nécessitant un tel traitement par administration à l'animal d'une composition pharmaceutique contenant une quantité efficace anti-inflammatoire d'un composé aldéhyde organique ou d'un dérivé de celui-ci dans un véhicule pharmaceutiquement acceptable.